Navigation Links
UCSF enters drug discovery agreement with Genentech
Date:2/18/2010

Wells said. "This collaboration shows how a center like the SMDC can help support the path from new biology into therapeutic products to help improve patients' lives."

This collaboration builds upon the existing master agreement between Genentech and UCSF, which allows the two to collaborate in a streamlined manner.

"We are very pleased to enter this agreement and are hopeful that together we can develop new treatments to help people with neurodegenerative diseases," said Marc Tessier-Lavigne, PhD, executive vice president, research and chief scientific officer of Genentech. "To date we have entered into more than 15 research collaborations with UCSF, across several therapeutic areas. We believe that this latest agreement with SMDC enhances our relationship with the University and creates a new model for important industry-academic drug development partnerships."

The partnership also coincides with the UCSF School of Pharmacy's goal of shaping the future of pharmacy science by working in fresh, collaborative ways, according to Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy.

"This is a tremendous new partnership and one that fits perfectly with one of the school's major strategic goals," Koda-Kimble said. "Our work with QB3 is a great example of how we are doing this. We believe the new UCSF partnership with Genentech takes this to a whole new level."

The SMDC offers all UC biomedical researchers access to modern small-molecule discovery technologies, including high-throughput screening and follow-up medicinal chemistry. The center performs biochemical and cell-based assays using liquid handling robots and a screening library of more than 180,000 compounds. It also houses a group of medicinal chemistry researchers who optimize screening hits into drug leads. Over the past four years, the center has grown to 18 biologists and chemists, many with pharmaceutical experience.

The center is based on
'/>"/>

Contact: Kristen Bole
kbole@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. UCSF Enters Drug Discovery Agreement with Genentech
2. International Merchant Advisors Inc. to Open New Wellness Centers With Medical Marijuana Treatment Facilities
3. MedCath Enters Definitive Agreement To Sell Heart Hospital of Austin
4. Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire Lacombe Medical Office Building Near New Orleans
5. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
6. New High Purity Immunoglobulin Enters Phase III in Europe and the US
7. Minorities Not Treated at Higher-Quality Centers
8. Summit VetPharm Enters Agreement With MWI Veterinary Supply to Distribute Vectra(R) Products
9. Sleep HealthCenters to Sponsor North East Sleep Society 2010
10. Binson's Home Health Care Centers Donates over $10,000 for Haiti Relief
11. Bariatricfurnishings.com Launches Unique Eco-friendly Seating for Health Care, Hospitality, Assisted Living Centers, and Home Use at Competitive Prices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, the US ... counseling for persons who are obese and those who are overweight with at least ... mandate will affect any commercial health plan with a program year start after August ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, ... brain volumes that may be early indicators of Alzheimer’s disease and dementia, according ... that vascular risk factors damage the brain and can result in cognitive impairment,” ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National ... a 2015 Professional Woman of the Year. Ms. Baum-Lappe is recognized with this ... professional women in the country, spanning virtually every industry and profession, the National ...
(Date:7/27/2015)... ... July 27, 2015 , ... The FSH Society ... incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced the introduction of the first-ever ... care guideline is published today. , This new guideline condenses the results ...
(Date:7/27/2015)... ... July 27, 2015 , ... Eugene Batelli, D.P.M., F.A.C.F.A.S, just recently ... “The patient is high-end athlete, whose accomplishments include running in 27 triathlons and swimming ... pain, which was diagnosed as tendinitis. I did an ultrasound and found a ...
Breaking Medicine News(10 mins):Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3
... AMDL, Inc. (NYSE Alternext US: ADL) , a ... its Chairman and CEO Mr. Douglas MacLellan has appeared ... 4, 2009 at 6:40 a.m. ET (3:40 a.m. PT). ... Fox Business News to discuss the Chinese business environment ...
... to Advance Understanding and Treatment of Pulmonary Fibrosis ... for Pulmonary Fibrosis (CPF) and the American Thoracic ... pulmonary, critical care and sleep physicians, today announced ... University Medical Center (Columbus, OH) and Harikrishna ...
... to share their heart-healthy lifestyle choicesDALLAS, Feb. 4 ... while others are life changing. Heart disease is the ... research shows that eighty percent of cardiac events in ... choices for their hearts, involving diet, exercise and abstinence ...
... Invisicare to ChinaLAS VEGAS and PLAINSBORO, N.J., Feb. 4 ... the developers of Invisicare , a ... for topical products, and RHEI Pharmaceuticals NV, a Belgium ... China, today announced they have signed a first option ...
... (Nasdaq: CADX ), a biopharmaceutical company focused ... for use in the hospital setting, announced today that ... the company,s corporate overview on Tuesday, February 10, 2009 ... BIO CEO and Investor Conference at the Waldorf Astoria ...
... Several big names in professional football and television ... 28 for the Third Annual National Walk for Epilepsy. ... Alan Faneca, and Atlanta Falcons running back Jason Snelling, ... their own teams of friends, relatives and fans. Together ...
Cached Medicine News:Health News:AMDL Inc.'s Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009 2Health News:AMDL Inc.'s Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009 3Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 2Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 3Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 4Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 2Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 3Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 4Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 2Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 3Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 4Health News:Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C. 2Health News:Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C. 3
(Date:7/27/2015)... , July 28, 2015 CTI BioPharma ... plans to report its second quarter 2015 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
(Date:7/27/2015)... PARIS , July 28, 2015   ... entered into a new global collaboration to discover, develop ... field of immuno-oncology. As part of the agreement, the ... protein 1 (PD-1) inhibitor currently in Phase 1 testing ... new therapeutic candidates based on ongoing, innovative preclinical programs. ...
(Date:7/27/2015)... WESTLAKE VILLAGE, Calif. , July 27, ... and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today ... granted early termination of the waiting period under the ... respect to Allergan,s pending acquisition of KYTHERA.  ... July 6, 2015, each of Allergan and KYTHERA filed ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
... The Transfusion Safety Management system ensures your ... and care. , BloodTrack SafeTx uses the ... patient from sample collection to transfusion. SafeTx ... and reduces the need for bedside paperwork ...
... wCareCollect™ improves the specimen collection process. A ... information on the handheld at the bedside. ... the specific patient. Collection status information can ... which can reduce redraws, enhancing patient comfort, ...
... System is a custom-designed nursing ... safety while improving overall efficiency. ... managing a myriad of tasks ... linked real-time to the hospitals ...
Med Administration Check closes the loop on the medication use process by automatically validating and documenting medication administration....
Medicine Products: